Form Type: 4

SEC EDGAR Link
Acccession Number:0001104659-20-004419
Date:2020-01-13
Issuer: ADAPTIMMUNE THERAPEUTICS PLC (ADAP)
Original Submission Date:

Reporting Person:

NOBLE JAMES
C/O ADAPTIMMUNE THERAPEUTICS PLC,
60 JUBILEE AVENUE, MILTON PARK ABINGDON, X0 OX14 4RX

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
AMERICAN DEPOSITARY SHARES 2020-01-13 S 100,000 d $4.00 0 direct
AMERICAN DEPOSITARY SHARES 2020-01-13 S 200,000 d $5.00 0 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on june 28, 2019.
f2 these adss were sold in multiple transactions at a price of $4.00. upon request, the reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the securities and exchange commission full information regarding the adss sold at this price in this footnote.
f3 these adss were sold in multiple transactions at a price of $5.00. upon request, the reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the securities and exchange commission full information regarding the adss sold at this price in this footnote.

Elevate your investments